高级检索
当前位置: 首页 > 详情页

Modulation of TRPV4 and BKCa for treatment of brain diseases

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650500, Yunnan, Peoples R China [2]Kunming Univ Sci & Technol, Dept Anesthesiol, Affiliated Hosp, Kunming 650032, Yunnan, Peoples R China [3]Kunming Univ Sci & Technol, Sch Med, Kunming 650500, Yunnan, Peoples R China [4]Kunming Univ Sci & Technol, Dept Neurosurg, Affiliated Hosp, Kunming 650032, Yunnan, Peoples R China
出处:
ISSN:

关键词: TRPV4 BKCa Alzheimer's disease Cerebral ischemia Brain tumor Epilepsy Headache

摘要:
As a member of transient receptor potential family, the transient receptor potential vanilloid 4 (TRPV4) is a kind of nonselective calcium-permeable cation channel, which belongs to non-voltage gated Ca2+ channel. Largeconductance Ca2+-activated K+ channel (BKCa) represents a unique superfamily of Ca2+-activated K+ channel (KCa) that is both voltage and intracellular Ca2+ dependent. Not surprisingly, aberrant function of either TRPV4 or BKCa in neurons has been associated with brain disorders, such as Alzheimer's disease, cerebral ischemia, brain tumor, epilepsy, as well as headache. In these diseases, vascular dysfunction is a common characteristic. Notably, endothelial and smooth muscle TRPV4 can mediate BKCa to regulate cerebral blood flow and pressure. Therefore, in this review, we not only discuss the diverse functions of TRPV4 and BKCa in neurons to integrate relative signaling pathways in the context of cerebral physiological and pathological situations respectively, but also reveal the relationship between TRPV4 and BKCa in regulation of cerebral vascular tone as an etiologic factor. Based on these analyses, this review demonstrates the effective mechanisms of compounds targeting these two channels, which may be potential therapeutic strategies for diseases in the brain.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 生化与分子生物学 3 区 药物化学 3 区 有机化学
最新[2023]版:
大类 | 3 区 医学
小类 | 2 区 有机化学 3 区 生化与分子生物学 3 区 药物化学
JCR分区:
出版当年[2019]版:
Q2 CHEMISTRY, MEDICINAL Q2 CHEMISTRY, ORGANIC Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版:
Q1 CHEMISTRY, ORGANIC Q2 CHEMISTRY, MEDICINAL Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 CHEMISTRY, MEDICINAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650500, Yunnan, Peoples R China [2]Kunming Univ Sci & Technol, Dept Anesthesiol, Affiliated Hosp, Kunming 650032, Yunnan, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82490 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号